Navigation Links
Surgeons develop simpler way to cure atrial fibrillation

Physicians have an effective new option for treating atrial fibrillation, a common irregular heart rhythm that can cause stroke. Heart surgeons at Washington University School of Medicine in St. Louis have developed and tested a device that radically shortens and simplifies a complex surgical procedure that has had the best long-term cure rate for persistent atrial fibrillation.

The simplified procedure is termed Cox-maze IV, and the surgeons believe it can replace the older "cut and sew" Cox-maze III in which ten precisely placed incisions in the heart muscle created a "maze" to redirect errant electrical impulses.

"This technology has made the Cox-maze procedure much easier and quicker to perform," says Ralph Damiano Jr., M.D., the John Shoenberg Professor of Surgery and chief of cardiac surgery at the School of Medicine and a cardiac surgeon at Barnes-Jewish Hospital. "Instead of reserving the Cox-maze procedure for a select group of patients, we would urge use of this device for virtually all patients who have atrial fibrillation and are scheduled for other cardiac surgery."

The device is a clamplike instrument that heats heart tissue using radiofrequency energy. By holding areas of the heart within the jaws of the device, surgeons can create lines of ablation, or scar tissue, on the heart muscle. In the older Cox-maze III procedure, the lines of ablation were made by cutting the heart muscle, sewing the incisions back together and letting a scar form. The ablation lines redirect the abnormal electrical currents responsible for atrial fibrillation, an irregular heart rhythm in which the upper heart chambers or atria wriggle like a bag of worms.

The Cox-maze procedure was developed at the University in 1987. In their latest clinical study, reported in the February issue of the Journal of Thoracic and Cardiovascular Surgery, University surgeons showed that Cox-maze IV is just as effective as Cox-maze III for curing atrial fibri
'"/>

Source:Washington University School of Medicine


Page: 1 2

Related biology news :

1. Penn Surgeons Use Completely Robotic Surgery to Successfully Treat Prostate Cancer
2. Surgeons with video game skill appear to perform better in simulated surgery skills course
3. A much-needed shot in the arm for HIV vaccine development
4. Clam embryo study shows pollutant mixture adversely affects nerve cell development
5. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
6. Scientists develop new color-coded test for protein folding
7. Zebrafish may hold key to understanding human nerve cell development
8. First real-time view of developing neurons reveals surprises, say Stanford researchers
9. Scientists identify new model Of NK cell development
10. Influenza vaccine uses insect cells to speed development
11. Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals

Post Your Comments:
(Date:11/24/2009)..., NEW YORK (November 24, 2009) -- Th...day a report revealing that the last remaining pop...nificantly due to the rising tide of poaching and ...will help inform Russian officials of what needs t...world,s biggest cat. , The report w...
(Date:11/24/2009)... What constitutes fish food is a matter of debate....at fish get almost 50 percent of their carbon from...between the terrestrial and aquatic ecosystems. ,...on shows this is not likely to be true. Algae prov...life, according to research published this week in...
(Date:11/24/2009)... This release is available in Spanish . , T...igher levels of inflammatory substances in the blo...t; as shown by a research project of the Universit..., a scientist at the School of Pharmacy. , The p...study in relation to the control of body weight an...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3It can be predicted the reaction obese patients will have to a diet 2Maternal child health focus of African Science Academies meeting in Ghana Nov 9 11 58053 1McDonalization of frogs 10037 1McDonalization of frogs 10037 2McDonalization of frogs 10037 3McDonalization of frogs 10037 4Independence Blue Cross Wins Disease Management Association of Americas Quality Award for Greatest Impact on Satisfaction 58048 1Independence Blue Cross Wins Disease Management Association of Americas Quality Award for Greatest Impact on Satisfaction 58048 2Independence Blue Cross Wins Disease Management Association of Americas Quality Award for Greatest Impact on Satisfaction 58048 3Independence Blue Cross Wins Disease Management Association of Americas Quality Award for Greatest Impact on Satisfaction 58048 4
...Common strains of tuberculosis-causing bacteria ha...ay tricks on cells in the lungs, scientists say. ,...s essentially welcome the bacteria into the lungs ... host becomes infected with the TB bacterium. But ...remains latent and the infected person never has a...
...wledge that the world,s oceans and atmosphere are ...xide into the Earth,s atmosphere. However, fewer p...also changingseawater is becoming more acidic as c... oceans. According to a paper to be published this...ium Research Institute, these changes in ocean tem...
...29, 2008-The Camille and Henry Dreyfus Foundation ...n the Chemical Sciences to recognize an individual...ed area of chemistry that has advanced the field i...he one of the largest awards dedicated to the chem...uled to be announced in April 2009. , The first D...
Other Biology News:TB bacterium uses its sugar coat to sweeten its chances of living in lungs 2TB bacterium uses its sugar coat to sweeten its chances of living in lungs 3TB bacterium uses its sugar coat to sweeten its chances of living in lungs 4Cranking up the volume 2
(Date:11/24/2009)...NTURE: HTL , TORONTO, Nov. 24 /PRNewswire-Fir...rly Calotto Capital Inc., a leading provider of ad...cell research and fertility clinic markets, today ... third quarter ended September 30, 2009. , , Q...on compared with $1.43 million in Q3 2008, - ...
(Date:11/24/2009)... DIEGO, Nov. 24, 2009 Ar...ed today that the company is scheduled to presen...ference on December 1, 2009 at 11:30 a.m. Eastern ...ce Hotel in New York City. Jack Lief, Arena,s Pres... provide an overview of the company, including its...
(Date:11/24/2009)...BOZEN, Italy, November 24 Health R...anadian joint venture with a group of selected,inv... will operate under the,name Health Robotics Canad...th Robotics, i.v. Room of the Future concept, whic....STATION(TM), i.v.SOFT(TM), and OMM(TM).,Health Ro...
(Date:11/24/2009)... Chemical Abstracts Service (CAS), the globa...na,s patent office is now the world,s leading prod.... China trailed Japan,s patent office, the World I...United States Patent and Trademark Office (USPTO) ...05, WIPO in 2006, and exceeded Japan for the first...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
...d., Feb. 27 Vaccinogen, Inc. announced that,its n...ll be commercially,available in Europe starting Ju...t commercially viable vaccine,for colon cancer," s...EO of,Vaccinogen. "It is the beginning of our worl...ns of the feasibility of patient specific anti-can...
...N WILL FOCUS ON COLLECTION, PROCESSING AND STORAGE...ENTAL TISSUE STEM CELLS, RANCHO CORDOVA, Calif., ...eading supplier of innovative products and,service...ed today that its,wholly-owned subsidiary, Vantus,...avis School of Veterinary Medicine,s Center for Eq...
...ves ReachBio exclusive North American distribution...ES cell-derived products for drug discov...TLE, Feb. 27 ReachBio LLC (Seattle, WA) announced...ne of Axiogenesis AG,(Cologne, Germany) to the Nor...ry market., (Logo: http://www.newscom.com/cgi-bi...
Other Biology Technology:Vaccinogen's New Anti-Cancer Vaccine Commercially Available in Europe This Year 2ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health 2ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health 3ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health 4ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health 5ReachBio Partners with Axiogenesis to Distribute Novel Cell-Based Products in North America 2ReachBio Partners with Axiogenesis to Distribute Novel Cell-Based Products in North America 3
Luciferase Control RNA from Promega
Rabbit Anti-Human NXF1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
20X TE buffer *RNase free* from Molecular Probes (Invitrogen)
Custom Human Cytokine Antibody Array, Choose from hundreds of proteins. from Raybiotech, Inc.
Biology Products: